bpc 157 intervertebral disc study Frontiers BPC-157 | Orthobiologics Associates

/ 12 , , , ,

The trial enrolled 300 obese subjects (BMI 27-35 kg/m) across multiple centers and randomized them to AOD-9604 (3 mg subcutaneous injection once or twice daily) or placebo for 12 weeks

Yesterdays labs (drawn at my new PCP visit) again show intact metabolic, renal, and hepatic synthetic function with the same low-borderline ALP and mild isolated bilirubin elevation that have persisted over time

You cant overdose

Or other absorption issues that limit B12 uptake

Sort of just found my passion and the answers I had been looking for with this new specialty finally after years of treating people with the Band-Aid fix it when its broken mentality instead of at the root cause. Mike has spent the last 10 years in Anti-Aging, Functional and Regenerative Medicine